Why… Oregon?
Business Oregon leaders discuss how the state's post-pandemic economic rebound is fueled by manufacturing, services, and wholesale trade.
Source: businessfacilities.com
📰 Ioscience News
Page 11 - Ioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ioscience. Real-time updates on events, politics, business and more.
Avanzanite Bioscience B.V.: Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal For the Treatment of Rare Kidney Disease in Germany, Austria, Switzerland and Greece
Advicenne agreement further validates Avanzanite's unique business model and establishes it as the go-to commercialization partner for medicines treating rare diseases across Europe Avanzanite
Source: finanznachrichten.de
Timeless Capital Corp. and Renaissance Bioscience Corp. Announce Terms of Private Placement in Connection with Qualifying Transaction
Calgary, Alberta--(Newsfile Corp. - February 28, 2023) - Timeless Capital Corp. (TSXV: TLC.P) ("Timeless" or the "Corporation") and Renaissance BioScience Corp. ("Renaissance") are pleased to announce
Source: finanznachrichten.de
Lexaria Bioscience Corp.: Lexaria Discovers Potential Novel Mechanism From Hypertension Study HYPER-H21-4
KELOWNA, BC / ACCESSWIRE / February 21, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce additional
Dennis Riedl George Jurcic Exchange Commission Lexaria Bioscience Corp Lexaria Bioscience Corp View Company Or Lexaria
Source: finanznachrichten.de
Yield10 Bioscience, Inc.: Yield10 Bioscience to Present at the Third Annual Winter Wonderland - Best Ideas 2023 Virtual Conference on February 21, 2023
WOBURN, MA / ACCESSWIRE / February 16, 2023 / Yield10 Bioscience, Inc. (NASDAQ:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, has been invited to present at the Third Annual Winter
Source: finanznachrichten.de
Alligator Bioscience & Aptevo Therapeutics Announce Dosing of First Patient with ALG.APV-527 in Phase 1 Clinical Trial
Trial to Evaluate Safety, Tolerability and Clinical Activity in Solid Tumors Expressing 5T4LUND, SWEDEN and SEATTLE, WA / ACCESSWIRE / February 13, 2023 / Alligator Bioscience AB ("Alligator") (Nasdaq
United States Miriam Weber Miller Aptevo Therapeuticsview Guillaume Van Renterghem Marvin White Exchange Commission
Source: finanznachrichten.de
Skye Bioscience, Inc.: Skye Bioscience Doses Second Cohort of Phase 1 Clinical Trial of SBI-100 Ophthalmic Emulsion
San Diego, California--(Newsfile Corp. - February 13, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative
Source: finanznachrichten.de
Arix Bioscience PLC: Director/PDMR Shareholding
DJ Director/PDMR Shareholding Arix Bioscience PLC (ARIX) Director/PDMR Shareholding 06-Feb-2023 / 17:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is
Arix Bioscience Schwierige Zeiten Kin Company Secretarial News Service Regulatory Announcement Director Shareholding
Source: finanznachrichten.de
Twist Bioscience Corporation Reports Earnings Results for the First Quarter Ended December 31, 2022
Twist Bioscience Corporation reported earnings results for the first quarter ended December 31, 2022. For the first quarter, the company reported sales was USD 54.24 million compared to USD 42.02... | February 5, 2023
Twist Bioscience Corporation Twist Bioscience Corporation Stock Exchange Press Release Sd Twst Us90184d1000
Source: marketscreener.com
Arix Bioscience PLC: Board Change
DJ Board Change Arix Bioscience PLC (ARIX) Board Change 26-Jan-2023 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the
Source: finanznachrichten.de